Viral Load - Non-Smoker All Patients % OLSAH Chi Square Test P-Value
<40 137 36.3% 2.2% 3 17.2374 0.0006
40 - 10000 76 20.2% 3.9% 3
>10000 65 17.2% 16.9% 11
unknown 99 26.3% 11.1% 11
Viral Load - Smoker All Patients % OLSAH Chi Square Test P-Value
<40 20 35.1% 0.0% 0 7.7561 0.0478
40 - 10000 15 40.5% 6.7% 1
>10000 6 27.3% 33.3% 2
unknown 16 33.3% 6.3% 1
Viral Load - CD4 cell count(< 200) All Patients % OLSAH Chi Square Test P-Value
40 - 10000 32 18.1% 6.1% 2 13.1065 0.0038
<40 33 18.6% 0.0% -
unknown 66 37.3% 26.1% 17
>10000 46 26.0% 13.6% 6
Viral Load - CD4 cell count(200 - 500) All Patients % OLSAH Chi Square Test P-Value
40 - 10000 47 26.6% 4.3% 2 0.5377 0.9401
<40 85 48.0% 2.4% 2
unknown 23 13.0% 4.5% 1
>10000 22 12.4% 4.3% 1
Viral Load - CD4 cell count(> 500) All Patients % OLSAH Chi Square Test P-Value
<40 35 70.0% 2.9% 1 0.4286 1
unknown 5 10.0% 0.0% 0
>10000 3 6.0% 0.0% 0
40 - 10000 7 14.0% 0.0% 0
Viral Load – ART
(not started)
All Patients % OLSAH Chi Square Test P-Value
<40 1 5.9% 0.0% 0 1.1636 1
40 - 10000 1 5.9% 0.0% 0
>10000 0 0.0% 0.0% 0
unknown 15 88.2% 40.0% 6
Viral Load – ART Type 1 All Patients % OLSAH Chi Square Test P-Value
<40 120 35.2% 1.7% 2 12.9821 0.0042
40 - 10000 73 21.4% 5.5% 4
>10000 52 15.2% 15.4% 8
unknown 96 28.2% 5.2% 5
Viral Load – ART Type 2 All Patients % OLSAH Chi Square Test P-Value
<40 6 35.3% 0.0% 0 7.5 0.1176
40 - 10000 6 35.3% 0.0% 0
>10000 3 17.6% 0.0% 0
unknown 2 11.8% 50.0% 1
Viral Load – ART Salvage All Patients % OLSAH Chi Square Test P-Value
<40 31 51.7% 3.2% 1 10.8687 0.0143
40 - 10000 11 18.3% 0.0% 0
>10000 16 26.7% 31.3% 5
unknown 2 3.3% 0.0% 0
Viral Load - Neutrophil count(<2) All Patients % OLSAH Chi Square Test P-Value
<40 45 28.1% 0.0% 0 6.9433 0.063
40 - 10000 40 25.0% 7.5% 3
>10000 33 20.6% 15.2% 5
unknown 42 26.3% 11.9% 5
Viral Load - Neutrophil count(≥2) All Patients % OLSAH Chi Square Test P-Value
<40 100 46.1% 3.0% 3 11.4183 0.0087
40 - 10000 40 18.4% 2.5% 1
>10000 32 14.7% 18.8% 6
unknown 45 20.7% 8.9% 4
Neutrophil Count – Age(20 - 30) All Patients Percentage OLSAH Chi Square Test P-Value
<2 26 32.1% 3.8% 1 0.5982 0.7415
≥2 48 59.3% 6.3% 3
unknown 7 8.6% 0.0% -  
Neutrophil Count – Age(31 - 40) All Patients % OLSAH Chi Square Test P-Value
<2 66 36.1% 6.1% 4 1.783 0.4375
≥2 89 48.6% 7.9% 7
unknown 28 15.3% 14.3% 4
Neutrophil Count – Age(41 - 50) All Patients % OLSAH Chi Square Test P-Value
<2 47 39.5% 10.6% 5 2.2398 0.3828
≥2 61 51.3% 4.9% 3
unknown 11 9.2% 0.0% -  
Neutrophil Count – Age(51 - 60) All Patients % OLSAH Chi Square Test P-Value
<2 19 41.3% 15.8% 3 0.899 0.8303
≥2 17 37.0% 5.9% 1
unknown 10 21.7% 10.0% 1
Neutrophil Count - CD4(<200) All Patients % OLSAH Chi Square Test P-Value
<2 76 42.9% 11.8% 9 0.7827 0.6982
≥2 80 45.2% 12.5% 10
unknown 21 11.9% 19.0% 4
Neutrophil Count - CD4(200 - 500) All Patients % OLSAH Chi Square Test P-Value
<2 74 41.8% 4.1% 3 0.5877 1
≥2 89 50.3% 3.4% 3
unknown 14 7.9% 0.0% -  
Neutrophil Count - CD4(> 500) All Patients % OLSAH Chi Square Test P-Value
<2 4 8.0% 0.0% -   0.2195 1
≥2 41 82.0% 2.4% 1
unknown 5 10.0% 0.0% -  
CD4 count - No. of years diagnosed with HIV (0-7) All Patients % OLSAH Chi Square Test P-Value
200 - 500 149 38.6% 2.7% 4 11.2656 0.0121
<200 165 42.7% 11.5% 19
> 500 44 11.4% 2.3% 1
unknown 28 7.3% 7.1% 2
CD4 count - No. of years diagnosed with HIV (8-13) All Patients % OLSAH Chi Square Test P-Value
200 - 500 20 54.1% 10.0% 2 3.5325 0.3909
<200 10 27.0% 30.0% 3
> 500 5 13.5% 0.0% 0
unknown 2 5.4% 0.0% 0
CD4 count - No. of years diagnosed with HIV (>14) All Patients % OLSAH Chi Square Test P-Value
200 - 500 7 70.0% 0.0% 0 9 0.3
<200 1 10.0% 100.0% 1
> 500 1 10.0% 0.0% 0
unknown 1 10.0% 0.0% 0
CD4 count – Gender(F) All Patients % OLSAH Chi Square Test P-Value
200 - 500 128 43.1% 1.6% 2 17.0343 0.0014
<200 103 34.7% 14.6% 15
> 500 44 14.8% 2.3% 1
unknown 22 7.4% 9.1% 2
CD4 count – Gender(M) All Patients % OLSAH Chi Square Test P-Value
200 - 500 47 35.1% 8.5% 4 1.8831 0.6001
<200 72 53.7% 11.1% 8
> 500 6 4.5% 0.0% 0
unknown 9 6.7% 0.0% 0
Table 3: Multivariate analysis of individual parameters as predictors for the development of OLSAH.
Goto home»